AAAAAA
Results:
1-16
|
Results: 16
Authors:
Belani, CP
Citation: Cp. Belani, Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancer, SEMIN ONCOL, 28(4), 2001, pp. 14-16
Authors:
Sweeney, CJ
Zhu, JM
Sandler, AB
Schiller, J
Belani, CP
Langer, C
Krook, J
Harrington, D
Johnson, DH
Citation: Cj. Sweeney et al., Outcome of patients with a performance status of 2 in Eastern cooperative oncology group study E1594 - A phase III trial in patients with metastatic nonsmall cell lung carcinoma, CANCER, 92(10), 2001, pp. 2639-2647
Authors:
Belani, CP
Einzig, A
Bonomi, P
Dobbs, T
Capozzoli, MJ
Earhart, R
Cohen, LJ
Luketich, JD
Citation: Cp. Belani et al., Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer, ANN ONCOL, 11(6), 2000, pp. 673-678
Authors:
Ramanathan, RK
Rubin, JT
Ohori, NP
Belani, CP
Citation: Rk. Ramanathan et al., Dramatic response of adult Wilms tumor to paclitaxel and cisplatin, MED PED ONC, 34(4), 2000, pp. 296-298
Authors:
Belani, CP
Citation: Cp. Belani, Combined modality therapy for unresectable stage III non-small cell lung cancer - New chemotherapy combinations, CHEST, 117(4), 2000, pp. 127S-132S
Authors:
Belani, CP
Citation: Cp. Belani, Paclitaxel and docetaxel combinations in non-small cell lung cancer, CHEST, 117(4), 2000, pp. 144S-151S
Authors:
Calvo, AR
Belani, CP
Citation: Ar. Calvo et Cp. Belani, Lung cancer: Therapeutic options for stage IV and recurrent NSCLC, CANC TREAT, 2000, pp. 189-227
Authors:
Bahri, S
Flickinger, JC
Kalend, AM
Deutsch, M
Belani, CP
Sciurba, FC
Luketich, JD
Greenberger, JS
Citation: S. Bahri et al., Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams, RADIAT ON I, 7(5), 1999, pp. 297-308
Authors:
Luketich, JD
Nguyen, NT
Weigel, TL
Keenan, RJ
Ferson, PF
Belani, CP
Citation: Jd. Luketich et al., Photodynamic therapy for treatment of malignant dysphagia, SURG LA E P, 9(3), 1999, pp. 171-175
Authors:
Fossella, F
Rigas, JR
Belani, CP
Citation: F. Fossella et al., New options in the treatment of non-small cell lung cancer, ANTI-CANC D, 10, 1999, pp. S25-S28
Authors:
Belani, CP
Citation: Cp. Belani, Paclitaxel and carboplatin with thoracic radiation - Locally advanced non-small-cell lung cancer, ONCOLOGY-NY, 13(9), 1999, pp. 54-59
Authors:
Belani, CP
Kearns, CM
Zuhowski, EG
Erkmen, K
Hiponia, D
Zacharski, D
Engstrom, C
Ramanathan, RK
Capozzoli, MJ
Aisner, J
Egorin, MJ
Citation: Cp. Belani et al., Phase I trial, including pharmacokinetic and pharmacodynamic correlations,of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer, J CL ONCOL, 17(2), 1999, pp. 676-684
Authors:
Belani, CP
Citation: Cp. Belani, Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: Results and future developments, SEMIN ONCOL, 26(3), 1999, pp. 15-18
Authors:
Selvaggi, G
Belani, CP
Citation: G. Selvaggi et Cp. Belani, Carboplatin and paclitaxel in non-small cell lung cancer: The role of amifostine, SEMIN ONCOL, 26(2), 1999, pp. 51-60
Authors:
Belani, CP
Citation: Cp. Belani, Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 44-54
Authors:
Kindler, HL
Belani, CP
Herndon, JE
Vogelzang, NJ
Suzuki, Y
Green, MR
Citation: Hl. Kindler et al., Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma - Sequential phase II trials by the cancer and leukemia group B, CANCER, 86(10), 1999, pp. 1985-1991
Risultati:
1-16
|